TOP-358-YI Non-HAP CAM-A ALG-006746 and ALG-006780 induce rapid HBsAg reductions in AAV-HBV mice and have favorable pharmacokinetic profiles von Vanrusselt, Hannah, Verheyen, Jordi, Gupta, Kusum, Degrauwe, Lars, Liu, Cheng, Sanchez, Abel Acosta, Bollier, Mélanie, Nshimyumuremyi, Jean-Boris, Verburgh, Benjamin, Peter, Clovis, Zhang, Qingling, Blatt, Lawrence, Beigelman, Leonid, Symons, Julian, Chanda, Sushmita, Smith, David, Jekle, Andreas, Vendeville, Sandrine, McGowan, David, Debing, Yannick

Volltext

FRI-272 - An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients von Debing, Yannick, Vanrusselt, Hannah, Degrauwe, Lars, de Oliveira, Daniel Apolônio Silva, Kariuki, Christopher, Ebwanga, Ebanja Joseph, Bashir, Shahbaz, Merckx, Wouter, Thatikonda, Santhosh, Gohil, Vikrant, Smith, David, Raboisson, Pierre, Montero, Saul, Hong, Jin, Sanchez, Abel Acosta, Blatt, Lawrence, Symons, Julian, Lin, Tse-I, Beigelman, Leonid, Paeshuyse, Jan

Volltext

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients von Debing, Yannick, Vanrusselt, Hannah, Degrauwe, Lars, de Oliveira, Daniel Apolônio Silva, Kariuki, Christopher, Ebwanga, Ebanja Joseph, Bashir, Shahbaz, Merckx, Wouter, Thatikonda, Santhosh, Gohil, Vikrant, Smith, David, Raboisson, Pierre, Montero, Saul, Hong, Jin, Sanchez, Abel Acosta, Blatt, Lawrence, Symons, Julian, Lin, Tse-I, Beigelman, Leonid, Paeshuyse, Jan

Volltext

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients von Debing, Yannick, Vanrusselt, Hannah, Degrauwe, Lars, Apolônio Silva de Oliveira, Daniel, Kariuki, Christopher Kinyanjui, Ebwanga, Ebanja Joseph, Bashir, Shahbaz, Merckx, Wouter, Thatikonda, Santhosh Kumar, Rajwanshi, Vivek, Gohil, Vikrant, Hong, Jin, Kum, Dieudonné Buh, Sanchez, Abel Acosta, Chanda, Sushmita, Blatt, Lawrence M, Jekle, Andreas, Symons, Julian A, Smith, David B, Raboisson, Pierre, Lin, Tse-I, Beigelman, Leonid, Paeshuyse, Jan

Volltext

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients von Debing, Yannick, Vanrusselt, Hannah, Degrauwe, Lars, Silva de Oliveira, Daniel Apolônio, Kariuki, Christopher Kinyanjui, Ebwanga, Ebanja Joseph, Bashir, Shahbaz, Merckx, Wouter, Thatikonda, Santhosh Kumar, Rajwanshi, Vivek, Gohil, Vikrant, Hong, Jin, Kum, Dieudonné Buh, Acosta Sanchez, Abel, Chanda, Sushmita, Blatt, Lawrence M., Jekle, Andreas, Symons, Julian A., Smith, David B., Raboisson, Pierre, Lin, Tse-I, Beigelman, Leonid, Paeshuyse, Jan

Volltext